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Abstract	
	
MK-STYX	[MAPK	(mitogen-activated	protein	kinase)	phosphoserine/threonine/tyrosine-
binding	protein]	is	a	pseudophosphatase	member	of	the	dual-specificity	family	subfamily	
of	protein	tyrosine	phosphatases.	MK-STYX	lacks	the	essential	cysteine	in	its	signature	
motif	required	for	catalytic	activity.	However,	mutations	to	“restore”	the	signature	motif	
result	in	a	catalytically	active	phosphatase,	MK-STYXactive	(F1).	We	reported	that	MK-STYX	
interacts	with	G3BP-1	[Ras-GAP	(GTPAse-activating	protein)	SH3	(Src	homology	3)	
domain	binding	protein-1],	and	inhibits	stress	granule	(SG)	formation	implicating	the	
pseudophosphatase	MK-STYX	in	the	stress	response	pathway.	SGs	are	large	structures	in	
which	untranslated	mRNAs	accumulate	and	may	serve	as	sites	of	mRNA	sorting,	when	
cells	are	under	stress.	Prolonged	stress	granules	are	associated	with	aggresome	
(misfolded	proteins)	formation;	cytotoxic	aggresomes	may	result	in	neurological	
disorders	such	as	amyotrophic	lateral	sclerosis	or	Alzheimer’s.	Fluorescence	microscopy	
data	demonstrate	that	MK-STYX	colocalizes	with	specific	aggresomes.	Coexpression	
experiments	in	HeLa	cells	with	MK-STYX	and	the	aggresome	marker	v-ErbA	show	that	
MK-STYX	colocalizes	to	v-ErbA	aggresomes	as	well	as	with	the	aggresome	marker	protein	
chimera	(GFP-250).	These	data	reveal	that	MK-STYX	localizes	to	aggresomes.	Taken	
together	with	our	prior	report	that	MK-STYX	inhibits	SGs,	this	work	may	illustrate	a	role	
for	MK-STYX	in	the	response	to	environmental	stress	through	regulation	of	protein	
synthesis.			
	
	 3	
Acknowledgments	
	
	 The	experience	I	have	had	in	Dr.	Hinton’s	research	lab	has	allowed	me	to	
develop	and	grow	as	both	a	person	and	a	scientist.	I	would	like	to	thank	Dr.	Hinton	for	
both	supporting	me	and	challenging	me.	Your	love	for	research	and	your	incredible	
ability	to	mentor	has	helped	inspire	my	decision	to	pursue	a	PhD.	I	would	also	like	to	
thank	my	committee	members	Dr.	Allison	and	Dr.	Aday	for	their	support	and	guidance	
through	the	honors	process.	I	would	like	to	thank	Vinny	Roggero	for	his	help	with	
microscopy.	I	wouldn’t	have	the	beautiful	images	I	do	without	it!	Thank	you	to	my	
incredibly	bright	and	capable	lab	mates	Arya	Dahal,	Patrick	Christian,	Adom	Whitaker,	
Christina	Stephens,	Yuming	Cao,	Andy	Mattei	and	Lauren	Mozingo.	Your	intelligence	and	
work	ethic	inspire	me	to	be	a	better	scientist.	Your	loyalty	and	generosity	as	a	friends	
inspire	me	to	be	a	better	person.	Thank	you	for	all	your	support!	I	would	also	like	to	
thank	Dallas	A.	Banks,	a	Hinton	lab	alumnus.	I	truly	look	up	to	you	and	hope	to	one	day	
be	as	good	a	scientist	as	you!	Thank	you	to	the	MANOS	research	team	for	pushing	me	to	
think	more	critically	about	our	social	context.	Thank	you	to	my	housemates	for	the	big	
and	little	things	you	do	to	support	me.	Finally,	I	want	to	thank	my	family.	Thank	you	for	
listening	to	me	gab	about	how	cool	research	is	and	being	there	for	me	during	the	rough	
patches.				 	
	 4	
	
Introduction		
	
	When	a	cell	is	under	stress,	it	uses	a	variety	of	mechanisms	to	maintain	cellular	
homeostasis.	Stress	granules	and	aggresomes	are	two	such	mechanisms.	These	
aggregating	bodies	form	and	degrade,	changing	the	composition	of	the	cell	environment	
depending	on	the	stress.	Chronic	stress	due	to	environmental	stimuli	or	mutations	can	
cause	these	mechanisms	to	become	dangerously	overactive.	Under	normal	conditions,	
RNA	binding	proteins	drive	the	formation	of	stress	granules.	Mutations	in	RNA	binding	
proteins	such	as	TAR	DNA	binding	protein	43	(TDP-43)	increase	their	propensity	to	
aggregate	and	form	stress	granules	that	are	a	hallmark	of	neurodegenerative	diseases,	
such	as	amyotrophic	lateral	sclerosis	(ALS)	and	frontotemporal	lobar	degeneration	
(FTLD)	pathology	(Colombrita	et	al.,	2009;	Neumann	et	al.,	2006).	These	currently	
incurable	neurodegenerative	diseases	are	heavily	associated	with	failures	in	the	cellular	
stress	response	pathway.	Characterizing	the	regulation	of	two	major	components,	stress	
granules	and	aggresomes,	could	contribute	to	novel	therapies	in	the	neurodegenerative	
disease	field.		
In	order	to	protect	the	cell,	translation	is	halted	and	mRNAs	are	accumulated	
into	stress	granules.	These	accumulated	mRNAs	are	suggested	to	be	non	essential	to	
deal	with	the	stressor.	mRNAs	whose	encoded	proteins	are	essential	to	deal	with	the	
stressor	are	thought	to	remain	in	the	cytosol	(Munchel	et	al.,	2011).	Stress	granules	
facilitate	the	development	of	a	protective	environment;	only	essential	proteins	are	
exposed	to	and	handle	the	stressor.	Nonessential	transcripts	are	protected	within	the	
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stress	granule	and	upon	removal	of	the	stressor,	they	return	to	be	translated	or	are	
degraded.	Stress	granules	allow	the	cell	to	maintain	homeostasis	under	stress	
conditions.		
Similar	to	stress	granules,	aggresomes	are	a	means	for	a	cell	to	maintain	its	
homeostatic	state	under	stress	conditions.	Stress	such	as	changes	in	heat,	pH	or	
oxidation	can	induce	the	misfolding	of	proteins.	A	proteins	fold	determines	its	function,	
and	particularly	toxic	protein	gain	of	function	can	result	from	protein	misfolding	
(Winklhofer	et	al.,	2008).	Misfolded	proteins	with	exposed	hydrophobic	portions	are	
prone	to	aggregation,	and	those	aggregates	are	moved	into	aggresomes.	Aggresomes	
sequester	toxic	and	nontoxic	misfolded	proteins	and	act	as	a	site	of	degradation	and	
sorting.	Upon	stressor	removal,	repaired	proteins	from	the	aggresome	are	restored	into	
the	cell	environment	or	proteins	are	degraded	through	autophagy	and	proteasomal	
degradation	(Johnston	et	al.,	1998;	Wong	et	al.,	2008).		
Aggregates	
	 The	function	of	a	protein	is	determined	by	its	structure.	Protein	misfolding	
can	result	in	a	change	or	loss	of	function	and	may	expose	hydrophobic	portions	of	that	
protein.	In	the	cellular	cytoplasm,	misfolded	hydrophobic	domains	or	folds	require	
energy	to	remain	exposed.	Through	the	process	of	mass	action	and	energy	
minimization,	these	hydrophobic	folds	facilitate	the	aggregation	of	proteins	(Dobson,	
2003).	
	 Protein	aggregation	can	be	cytoprotective	or	cytotoxic.	Cytoprotective	
aggregates	include	RNA	inclusion	bodies	such	as	processing	bodies	(P-bodies),	RNA	
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transport	bodies	and	stress	granules.	P-bodies	degrade	RNA	transcripts,	RNA	transport	
bodies	transport	neuronal	RNA,	and	stress	granules	store	and	sort	translationally	stalled	
mRNA	transcripts	(Parker	&	Sheth,	2007;	Wolozin,	2012).	In	response	to	cellular	stress,	
RNA	binding	proteins	bind	mRNA	transcripts.	These	proteins	and	mRNA	transcripts	
aggregate,	nucleate	and	mature	into	stress	granules.	Cellular	stress	also	elicits	the	
formation	of	aggregate	bodies	called	aggresomes	(Garcia-Mata,	Bebok,	Sorscher,	&	
Sztul,	1999).	Aggresomes	consist	primarily	of	misfolded	proteins	and	act	as	sites	of	
misfolded	protein	sorting,	degradation	and	repair.		
	 Stress	granules	and	aggresomes	are	cytoprotective	under	normal	
physiological	conditions.	Malfunction	or	mutations	in	the	signaling	pathways	that	
facilitate	stress	granule	and	aggresome	formation	can	lead	to	persistence	of	these	
protein	aggregates	and	detrimental	effects	to	the	cell	(Lu	et	al.,	2015).	This	aggregate	
persistence,	growth,	and	potential	cytotoxicity	is	associated	with	many	harmful	diseases	
known	as	conformational	diseases.		
	 A	commonly	known	example	is	Alzheimer’s	disease	(AD).	AD	is	a	
neurodegenerative	disease	with	no	known	cure.	Affecting	5.4	million	Americans	
(http://www.alz.org/facts/#prevalence),	AD	is	a	debilitating	disease	that	manifests	in	
memory	loss,	loss	of	speech	and	an	inability	to	recognize	people	or	objects	(Kumar	et	
al.,	2015).	This	frightening	neurodegenerative	disease	is	characterized	by	the	presence	
of	toxic	stress	granules	and	aggresomes	(Olzmann,	Li,	&	Chin,	2008;	Wolozin,	2012).		
	 Stress	granule	and	aggresome	aggregation	dynamics	are	regulated	by	
complicated	signaling	networks	(Tyedmers	et	al.,	2010;	Wolozin,	2012).	Understanding	
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the	signaling	pathways	involved	in	the	stress	granule	and	aggresome	life	cycle	is	
essential	for	characterizing	the	cellular	stress	response	pathway.	A	thorough	
characterization	may	reveal	answers	to	some	of	the	questions	regarding	
neurodegenerative	disease	pathology.		
Stress	granule	formation		
		 Stress	granules	are	cytoprotective	aggregates	of	translationally	stalled	mRNA	and	
proteins.	These	aggregates	have	a	life	cycle	of	assembly,	persistence	and	disassembly.	
Stress	granule	assembly	is	facilitated	through	a	collaboration	of	post	translational	
modification,	protein-protein	interaction	and	microtubule	network	dynamics.	Stress	
granule	initiation	and	assembly	is	driven	by	eukaryotic	initiation	factor	2	α	(eIF2α)	
phosphorylation	(Kedersha	et	al.,	1999).	Four	different	kinases	that	respond	to	different	
stressors	are	responsible	for	eIF2α	phosphorylation	:	PKR	(heat	shock,	UV	radiation,	viral	
infection),	PERK	(ER	stress),	GCN2	(starvation),	and	HR1	(hypoxia)	(Srivastava,	Kumar,	&	
Kaufman,	1998;	Wolozin,	2012).	A	regulatory	kinase	phosphorylates	eIF2α	at	site	serine-
51,	preventing	its	ability	to	form	the	GTP-tRNA-	eIF2α	complex	that	allows	for	
translation	of	mRNA	to	protein.	During	stress	granule	assembly,	RNA	binding	proteins	
such	as	G3BP1	[RAS-GAP	(GTPase-activating	protein)	SH3	(Src	homology	3)	domain-
binding	protein-1]	and	TIA-1	(T-cell-restricted	intracellular	antigen-1)	relocate	from	the	
nucleus	to	the	cytosol	making	them	available	to	bind	mRNA	(Kedersha	et	al.,	2000;	
Kedersha	et	al.,	1999;	Tourriere	et	al.,	2001).	Once	bound	to	mRNA,	the	protein	bound	
mRNA	or	ribonucleoprotein	(mRNP)	aggregate.	Aggregation	is	facilitated	by	the	RNA	
binding	protein	hydrophobic	prion-like	domains	(Gilks	et	al.,	2004).		Aggregates	are	
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moved	along	the	microtubule	network	by	dynein	motor	proteins,	meeting	and	fusing	
with	other	aggregates	to	nucleate	and	mature	into	the	larger	SG	(Tsai,	Tsui,	&	Wei,	
2009).			
Stress	granule	formation	is	variable	and	dynamic.	It	depends	on	the	mRNPs	
within	a	granule	and	those	are	likely	stressor	dependent	(Buchan	&	Parker,	2009).	
During	stress	granule	assembly,	capped	mRNAs	remain	in	the	pre-initiation	complex.	
This	complex	is	bound	by	eIF3,	poly	A	binding	proteins	and	nucleating	mRNPs.	Stress	
granule	nucleating	mRNPs	including	TIA-1,	tristetraprolin	(TTP),	TIAR	and	G3BP1	bind	
the	freed	mRNA	induce	aggregation.	The	mRNPs	aggregate	by	binding	each	others	
glycine	rich	domains	(Aulas	et	al.,	2015;	N.	Kedersha	et	al.,	2000;	Mazan-Mamczarz,	Lal,	
Martindale,	Kawai,	&	Gorospe,	2006).	Aggregation	is	facilitated	by	the	RNA	binding	
protein	hydrophobic	prion-like	domains	(Gilks	et	al.,	2004).		TDP-43	drives	the	secondary	
maturation	of	stress	granules	containing	G3BP1	specifically	(McDonald	et	al.,	2011).	
Another	important	component	of	stress	granule	assembly	is	microtubules.	Stress	
granules	initially	form	as	small	foci	and	are	then	transported	along	the	microtubule	
network	with	the	aid	of	motor	proteins	such	as	dynein	and	kinesin	to	form	larger	stress	
granules.	Stress	granules	require	microtubules	for	their	assembly,	but	do	not	require	
them	for	persistence	(Nadezhdina	et	al.,	2010;	Tsai	et	al.,	2009).		
The	signaling	cascades	that	regulate	stress	granule	formation	are	not	yet	well	
understood.	A	number	of	proteins	have	been	characterized	in	the	facilitation	of	stress	
granule	aggregation.	Histone	deacetylase	6	(HDAC6)	is	necessary	for	stress	granule	
formation	(Kawaguchi	et	al.,	2003).	It	can	deacetylate	tubulin	in	the	microtubule	
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network.	HDAC6	interacts	with	the	RNA	binding	protein	G3BP1	(Kwon,	Zhang,	&	
Matthias,	2007).	G3BP1	has	a	glycine	rich	domain	that	facilitates	aggregate	formation	
and	has	endoribonuclease	capabilities	(Tourriere	et	al.,	2001).	G3BP1	induces	stress	
granule	formation	when	dephosphorylated	at	serine-149	(Tourriere	et	al.,	2001).	
Furthermore,	immunoprecapitation	studies	showed	HDAC6	can	only	bind	G3BP1	when	
it	is	dephosphorylated	indicating	that	HDAC6	regulation	of	SG	is	dependent	on	G3BP1	
phosphorylation	state	(Kwon	et	al.,	2007).		
Stress	granules	(SG)	are	transient	in	their	formation.	They	form	within	a	few	
seconds	of	onset	of	stress.	As	the	cell	deals	with	the	stressor,	SGs	can	act	as	a	means	to	
inhibit	apoptosis.	SG	sequester	pro-apoptotic	proteins	including	RACK1,	ROCK1	and	
TRAF2	(Arimoto	et	al.,	2008).	They	also	sequester	signaling	molecules	and	proteins	that	
regulate	signaling	cascades	(Arimoto	et	al.,	2008).	
Stress	granule	persistence	can	be	a	result	of	mutations	or	chronic	oxidative,	
tropic	or	physical	stress.	Stress	granules	that	demonstrate	continual	growth	and	contain	
pathological	molecules	are	termed	autoreactive	stress	granules.	Autoreactive	stress	
granules	are	in	a	positive	feed	back	loop	with	the	formation	of	pathological	aggregates	
such	as	the	microtubule	associated	protein	tau	aggregates	(Vanderweyde	et	al.,	2012)	.	
During	stress	recovery,	stress	granules	disassemble	within	1-3	hours	(N.	L.	
Kedersha	et	al.,	1999).	Stress	granule	disassembly	is	dependent	on	the	molecular	
chaperone	The	70	kilodalton	heat	shock	protein	(HSP70),	and	the	presence	of	
microtubules.	The	disassembly	of	stress	granules	has	not	been	fully	characterized,	but	a	
	 10	
few	mRNPs	are	known	to	assist	in	stress	granule	disassembly.	Another	example	is	the	
phosphorylation	of	Grb7	by	focal	adhesion	kinase	(FAK)	is	necessary	to	weaken	
interactions	with	stress	granule	components	such	as	TIA-1	and	specific	mRNA	bindings	
(Tsai	et	al.,	2008).	Restoration	of	mRNA	translation	and	the	recovery	of	protein	synthesis	
correlates	with	stress	granule	disassembly	(Lian	&	Gallouzi,	2009;	Mazroui,	Di	Marco,	
Kaufman,	&	Gallouzi,	2007)	(Figure	1).	
	
Figure	1.	Under	normal	cytosolic	conditions	the	tRNA-GTP-eIF2α	complexes	with	
ribosomes	to	facilitate	the	translation	of	mRNA	into	protein.	When	the	cell	is	under	
stress,	kinases	such	as	PERK	phosphorylate	eIF2α.	This	prevents	the	formation	of	the	
tRNA-GTP-eIF2α	complex.	This	results	in	the	disassembly	of	the	ribosome.	RNA	binding	
proteins	such	as	TIA-1	and	G3BP1	export	from	the	nucleus	and	bind	the	freed	mRNA.	
The	RNA	binding	protein	hydrophobic	domains	drive	the	aggregation	of	the	protein	
bound	mRNA	into	small	aggregates.	These	aggregates	are	moved	along	the	microtubule	
network	by	histone	deacetylase	6	(HDAC6)	and	dynein	towards	a	forming	stress	granule.		
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Aggresomes	formation			
The	disruption	of	the	cell	environment	is	associated	with	protein	misfolding	from	
their	native	3D	fold.	As	a	means	of	energy	minimization,	misfolded	proteins	aggregate.	
Cellular	mechanisms	collect	these	smaller	foci	into	inclusion	bodies	of	storage,	sorting	or	
degradation	across	the	phyla.	From	yeast	to	mammalian	cells,	an	inclusion	body	of	
interest	is	the	aggresome	(Kiontke	&	Sudhaus,	2006).	Aggresomes	are	transient	and	
contain	dynamic	aggregates	of	misfolded	proteins,	chaperones	and	other	molecules.		
Aggresome	formation	begins	with	the	development	of	protein	aggregates.	The	
energy	barrier	between	separate	native	and	non-native	conformations	is	often	small	
enough	that	native	proteins	are	at	risk	of	stress	induced	misfolding	(Dobson,	2003).	At	
the	onset	of	cellular	stress,	protein	aggregates	form	and	the	motor	protein	dynein	
moves	them	by	retrograde	transport	along	microtubules.	Similar	to	stress	granule	
formation,	HDAC6	is	essential	for	aggresome	formation	as	it	acts	as	a	link	between	
misfolded	proteins	and	the	dynein	motor	(Kawaguchi	et	al.,	2003).	Dynein	moves	the	
aggregates	towards	the	microtubule-organizing	center	(MTOC).	The	MTOC	nucleates	
these	aggregates	as	they	eventually	develop	into	a	perinuclear	aggresomes	(Johnston	et	
al.,	1998).	These	non-membranous	bodies	recruit	chaperones	and	proteasomes	or	
trigger	autophagy	as	a	means	of	protein	repair	or	degradation.	Proteasomal	degradation	
does	occur	at	the	aggresome,	but	autophagy	is	more	common	for	the	degradation	of	
aggregated	protein	(Wong	et	al.,	2008).		
Aggresomes	are	thought	to	be	cytoprotective.	They	act	as	recruitment	centers	
for	the	degradation	of	cytotoxic	proteins	(Taylor,	2003).	α-Synuclein	is	a	soluble	
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unstructured	protein	whose	mutant	version	forms	insoluble	aggregates	in	Parkinson’s	
disease	pathology	(Quinn	et	al.,	2012).	In	a	study	of	α-Synuclein	and	its	interacting	
partner	Synphilin-1,	cDNA	treatment	with	microtubule	destabilizing	agents	and	a	
proteasome	inhibitor	resulted	in	fewer	cells	expressing	aggresomes.	Cells	that	did	not	
express	aggresomes	were	significantly	more	often	apoptotic	(Tanaka	et	al.,	2004).		
Aggresome	characteristics	include	the	development	of	a	vimentin	intermediate	
filament	(IF)	meshwork	into	a	cage	surrounding	the	aggresome,	mitochondrial	
recruitment,	nuclear	deformation,	and	disorganization	of	microtubule	networks.	The	
vimentin	cage	is	hypothesized	to	immobilize	and	contain	the	aggresome.	Mitochondrial	
recruitment	is	thought	to	provide	energy	for	protein	refolding	or	degradation	(Johnston	
et	al.,	1998).	These	defining	features	are	used	when	characterizing	novel	aggresome	
markers	(Figure	2).	
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Figure	2.	Unfolded	or	misfolded	proteins	originate	from	translating	polysomes,	
retrotranslocation	from	the	ER	to	the	cytosol,	or	proteins	damaged	by	stress.	If	and	
when	these	unfolded/misfolded	proteins	fail	to	correctly	fold	and	are	not	degraded	by	
the	proteasome	their	hydrophobic	properties	facilitate	their	aggregation	throughout	the	
cell.	Regulated	movement	of	these	aggregated	by	dynein	down	microtubules	towards	
the	microtubule	organizing	center	(MTOC)	nucleate	and	grow	the	forming	aggresomes.	
Aggresome	size	will	cause	nuclear	deformation	and	cytoskeletal	intermediate	filaments	
form	a	‘cage’	around	the	aggresome.		
	
Tau	Aggresomes		
	
The	microtubule	associated	protein	tau	has	been	recently	characterized	as	an	
aggresome	forming	protein.	This	protein	is	encoded	in	the	MAPT	gene	that	contains	16	
exons.	Tau	mRNA	is	spliced	to	form	multiple	isoforms	associated	with	different	
functions	and	life	cycles.	The	protein	exists	in	six	main	isoforms	in	the	human	brain.	The	
isoforms	are	characterized	by	the	number	of	amino	terminal	inserts	encoded	by	exon	2	
or	exon	3,	0N,	1N	and	2N	respectively.	The	isoforms	are	also	characterized	by	whether	
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they	contain	three	or	four	carboxy-terminal	repeat	domains,	3R	or	4R.	2N4R	is	the	full	
length	tau	isoform	(Lee,	Cowan,	&	Kirschner,	1988;	Wang	&	Mandelkow,	2016).	4R	is	
encoded	by	exon	10	which	is	of	interest	because	alternative	splicing	of	exon	10	is	
associated	with	distinct	tauopathies	(Dickson,	Kouri,	Murray,	&	Josephs,	2011).		
Tauopathies	are	diseases	associated	with	pathological	tau.	There	are	two	general	
types	of	tauopathies:	genetically	inherited	and	sporadic	disease.	In	genetically	inherited	
disease,	mutations	in	the	microtubule	binding	domain	are	often	attributed	to	tau	
aggregation	(Iqbal.,	2016).	In	sporadic	tau	aggregation,	environmental	factors	trigger	tau	
aggregation	in	patients	who	are	not	genetically	predisposed	(Wang	&	Mandelkow,	
2016).	Sporadic	tau	aggregation	is	currently	not	well	understood.		Understanding	the	
mechanisms	of	tau	aggregation	could	have	profound	implications	for	neurodegenerative	
disease	therapies	and	the	future	of	the	tauopathy	field.		
The	2N4R	and	1N4R	tau	isoforms	have	been	identified	as	forming	aggresomes.	
Secreted	paired	helical	filaments,	aggregates	associated	with	neurodegenerative	
disease,	are	taken	up	by	HEK293	model	cancer	cells	and	trigger	the	formation	of	
characterized	2N4R	tau	aggresomes.	This	formation	is	hypothesized	to	be	one	of	the	
first	steps	in	neurofibrillary	tangles	(NFT)	formation	(Santa-Maria	et	al.,	2012).	
Furthermore,	proteasome	inhibition	drives	the	HDAC6	dependent	formation	of	1N4R	
tau	aggresomes	(Guthrie	&	Kraemer,	2011).	
Tau	aggresomes	may	play	an	essential	role	in	the	propagation	of	
neurodegenerative	disease.	The	mechanism	of	this	tau	aggresome	formation	and	
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dissociation	is	still	being	characterized.	Identifying	a	protein	involved	in	the	regulation	of	
these	aggresomes	would	be	crucial	in	characterization	of	tauopathy	propagation.		
Regulatory	pseudophosphatases	
	 The	regulatory	signaling	of	stress	granule	and	aggresome	formation	is	poorly	
understood.	This	could	be	due	to	the	omission	of	critical	regulator	proteins	based	on	the	
protein	family	they	belong	to.	A	commonly	overlooked	type	of	protein	is	the	
pseudophosphatase	family.	There	was	a	general	notion	amongst	the	phosphatase	and	
signaling	field	that	pseudophosphatases	are	simple	proteins	that	lack	regulatory	
functions	aside	from	competitive	inhibition	(Tonks,	2009).	This	is	due	to	their	inability	to	
catalyze	the	dephosphorylation	of	a	substrate.	However,	the	phosphatase	field	is	
coming	to	accept	them	as	important	regulators.	A	pseudophosphatase	is	a	phosphatase	
that	has	the	same	catalytic	domain	and	fold	as	a	phosphatase,	but	due	to	a	difference	in	
amino	acids,	it	cannot	actually	dephosphorylate	a	protein	or	molecular	substrate.	Some	
pseudophosphatases	may	act	as	competitive	inhibitors,	but	that	by	no	means	
encompasses	the	role	of	these	proteins.		
Pseudophosphatases	make	up	approximately	8%	of	the	human	phosphatome,	
which	is	a	very	significant	percentage	for	a	protein	considered	to	be	non-regulatory.	
Indeed,	pseudophosphatases	have	been	shown	to	act	as	key	regulators	in	signaling	
pathways.	They	can	play	a	wide	variety	of	regulatory	roles	such	as	signal	integrators,	
modulators,	spatial	anchors	and	competitors	(Reiterer,	Eyers,	&	Farhan,	2014).	In	C.	
elegans,	two	pseudophosphatases	EGG-4	and	EGG-5	regulate	the	dual-specificity	
tyrosine-regulated	kinase	(DYRK)	termed	MBK-2	during	the	oocyte	to	zygote	transition.	
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MBK-2	phosphorylates	substrates	involved	in	the	breakdown	of	microtubules	and	the	
polarization	of	the	zygote.	The	EGG-4/5	pseudophosphatase	binds	the	
autophosphorylated	active	loop	of	MBK-2.	A	segment	of	bound	EGG-4/5	acts	as	a	
pseudosubstrate,	binding	the	MBK-2	substrate	binding	site.	This	inhibits	the	capacity	of	
the	kinase	MBK-2	to	bind	and	phosphorylate	substrates,	thus	demonstrating	the	
regulatory	role	of	the	pseudophosphatases	EGG-4	and	EGG-5	(Cheng,	Klancer,	Singson,	
&	Seydoux,	2009).		
		 The	pseudophosphatase	STYX,	named	after	the	Greek	mythological	river	STYX,	is	
a	good	example	of	the	impact	of	pseudophosphatase	regulation	on	physiological	
mechanisms.	STYX	plays	an	essential	role	in	spermatogenesis	by	complexing	with	RNA-
binding	protein	Crhsp-24	(calcium-responsive	heat-stable	protein	with	a	molecular	mass	
of	24	kDa).	In	fact,	knocking	out	STYX	in	mice	inhibited	spermatogenesis.	This	suggests	
that	the	pseudophosphatase	STYX	acts	as	regulator	in	mice	spermatogenesis	(Wishart,	
2002).		
Protein	Tyrosine	Phosphatases	
STYX	is	a	member	of	the	protein	tyrosine	phosphatase	(PTP)	super	family.	The	
protein	tyrosine	phosphatase	family	is	the	largest	family	of	phosphatase	genes.	These	
phosphatases	have	the	signature	motif	HCX5R.	The	cysteine	is	essential	for	
dephosphorylation.	It	catalyzes	the	nucleophilic	attack	that	dephosphorylates	the	
phosphosubstrate.	PTPs	use	this	catalytic	activity	in	the	regulation	of	fundamental	
cellular	processes	such	as	cell	growth,	differentiation	and	the	cell	cycle	(Andersen	et	al.,	
2004).		
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The	PTP	family	is	divided	into	the	classical	p-Tyr	specific	phosphatases	and	the	
dual	specificity	phosphatases	(DUSPs)	(Alonso	et	al.,	2004).	Classical	p-Tyr	specific	
phosphatases	can	only	dephosphorylate	phospho-tyrosine	while	difference	in	active	site	
conformation	enables	DUSPs	to	dephosphorylate	phospho-serine,	threonine	and	
tyrosine	residues	(Tonks,	2006).	DUSPs	have	little	sequence	similarity	beyond	their	
cysteine	containing	signature	motif,	making	them	a	difficult	and	interesting	family	to	
study.	
Mitogen	kinase	phosphatases	(MKPs)	fall	within	the	DUSP	family.	MKPs	are	a	
well-characterized	class	of	phosphatases	with	distinct	subcellular	localization	and	
specificity	for	individual	mitogen	activated	kinases	(Tonks,	2006).	A	pseudo-MKP	and	the	
subject	of	this	thesis	research,	is	the	pseudophosphatase	MK-STYX	[MAPK	(mitogen-
activated	protein	kinase)	phosphoserine/threonine/tyrosine-binding	protein].	
Interestingly,	MK-STYX	has	not	been	shown	to	have	much	functional	similarity	in	
relation	to	its	larger	family	nor	has	it	been	shown	to	fulfill	structural	predictions.		
The	pseudophosphatase	MK-STYX	
The	pseudophosphatase	MK-STYX	is	a	regulator	in	cancer	development	and	the	
cellular	stress	response	pathway.	MK-STYX	is	highly	expressed	in	Ewing’s	sarcoma	cells	
and	is	a	direct	target	of	the	transcription	factor	EWS-FLI1.The	transcription	factor	binds	
the	mk2-2	gene	fragment	within	the	163	bp	MK-STYX	sequence	and	induces	its	
transcription	(Siligan	et	al.,	2005).	MK-STYX	has	also	been	identified	as	an	important	
regulator	in	the	intrinsic	apoptotic	pathway	and	chemotherapy	resistance.	Knockdown	
studies	of	MK-STYX	resulted	in	resistance	to	mitochondrial	apoptosis,	the	block	of	
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cytochrome	c	release	and	chemoresistance	(Niemi	et	al.,	2011).	In	the	mitochondria	
mitoplast,	MK-STYX	is	known	to	bind	PTPMT1	(PTP	localized	to	mitochondrion	1)	and	
significantly	reduce	its	phosphatase	activity.	PTPMT1	inhibits	apoptosis	and	its	
knockdown	is	sufficient	to	induce	apoptosis	and	increase	chemosensitivity.	MK-STYX	
inhibits	PTPMT1	activity	and	is	thought	to	regulate	induction	of	apoptosis	in	part	with	
this	binding	partner.		
An	apoptotic	pathway	of	interest	is	the	p38	and	JNK	MAPKs	activation	(SAPK)	
apoptotic	pathway.	This	pathway	is	inhibited	by	the	formation	of	stress	granules,	
aggregates	of	translationally	stalled	mRNA	and	proteins	(Arimoto	et	al.,	2008).	
Interestingly,	MK-STYX	inhibits	and	regulates	the	formation	of	stress	granules	induced	
by	arsenite	stress	or	G3BP1	overexpression	(Hinton	et	al.,	2010).	G3BP1	is	a	heavily	
phosphorylated	RNA	binding	protein	whose	overexpression	is	sufficient	to	induce	stress	
granules.	Its	induction	of	stress	granules	is	heavily	dependent	on	its	dephosphorylation	
at	the	site	Ser-149	(Aulas	et	al.,	2015).		MK-STYX	inhibits	stress	granule	formation	
independent	of	the	phosphorylation	state	of	its	binding	partner	G3BP1.	Furthermore,	
the	active	mutant	that	can	dephosphorylate,	MK-STYXactive,	did	the	exact	opposite	of	
wild	type	MKSTYX.	Indeed,	the	MKSTYX	active	mutant,	a	mutant	with	an	amino	acid	
change	that	restores	catalytic	activity,	induced	stress	granule	formation	(Hinton	et	al.,	
2010).	Additionally,	it	induced	stress	granule	formation	when	co-overexpressed	with	a	
G3BP1	phosphomimic	that	cannot	be	dephosphorylated.	This	mimic	alone	cannot	form	
stress	granules,	but	will	form	stress	granules	in	the	presence	of	MK-STYXactive.	MK-STYX	
reduces	stress	granules,	but	it	does	not	colocalize	to	stress	granules.	This	raises	the	
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question	of	MK-STYX’s	colocalization	in	its	regulation	of	the	stress	response	pathway.		
Methods		
	
Plasmids		
pMT2-FLAG-MK-STYX-FLAG,	pMT2-FLAG-F1-FLAG,	pMT2,	pGFP-v-ErbA,	pGFP-
250,	G3BP-1-GFP,	and	GFP	plasmids	were	used	to	overexpress	MK-STYX,	MK-STYXactive	
(F1),	pMT2,	v-ErbA,	GFP-250,	G3BP1	and	GFP	respectively.	Overexpression	of	the	empty	
vector	pMT2	was	used	as	a	control	for	MK-STYX	or	MK-STYXactive	transfections.	GFP	was	
used	a	control	for	v-ErbA,	GFP-250	and	G3BP1	transfections.	Plasmids	were	stored	at	-
20°C.		pMT2-FLAG-MK-STYX-FLAG	and	pMT2-FLAG-F1-FLAG	were	previously	constructed	
by	Dr.	Shantá	D.	Hinton	using	methods	in	Hinton	et	al.,	2010.	The	pGFP-v-ErbA	and	
pGFP-250	were	kind	gifts	from	Dr.	Lizabeth	A.	Allison,	The	College	of	William	and	Mary.	
The	G3BP-1-GFP	construct	was	kindly	provided	by	Jamai	Tazi,	Institut	de	Génétique	
Moléculaire,	Montpellier,	France.	
Plasmids	were	transformed	into	E.	coli	DH5α	cells	and	grown	on	antibiotic	
containing	agar	plates	overnight.	The	pMT2	vector	plasmids	described	are	ampicillin	
resistant	and	the	GFP	containing	plasmids	are	kanamycin	resistant.	This	allowed	
assurance	that	the	bacterial	colonies	that	grew	contained	the	plasmid	of	interest.	
Bacterial	colonies	containing	plasmids	were	moved	into	flasks	containing	Luria	broth	
(LB)	media	and	shaken	over	night.	Plasmids	were	purified	from	the	bacterial	growth	
using	the	Qiagin	plasmid	midi	prep	kit	or	the	Zymo	research	ZymoPURE	midi	prep	kit.	
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Cell	Culture		
All	experiments	used	human	cervical	cancer	HeLa	cells	(ATCC	#CCL-2).	Cells	were	
grown	at	37°C,	98%	humidity,	and	5%	CO2	in	Minimum	Essential	Medium	(MEM)	
supplemented	with	Invitrogen	10%	fetal	bovine	serum	(FBS).	Cells	were	maintained	in	
filter-capped	75	cm2	flasks	(ThermoFisher	Scientific).	Cells	were	grown	to	80-90%	
confluency	and	then	split	into	another	flask	or	seeded	into	glass	cover	slip	containing	6	
well	plates	(ThermoFisher	scientific).	Cells	were	split	using	trypsin	serine	protease.	Cells	
were	washed	with	1x	DBPS	(Dulbecco’s	Phosphate	Buffered	Saline)	then	trypsinized	for	
three	minutes.	Cells	were	checked	under	the	light	microscope	to	visualize	detachment.	
Trypsinization	was	inactivated	by	the	addition	of	MEM.	Approximately	2mL	of	cells	were	
moved	into	another	flask	and	the	rest	of	the	cells	were	counted	using	a	hemocytometer	
and	diluted	in	MEM	to	achieve	a	total	of	2.0	x	105	cells	per	well	in	a	6	well	plate.	
Transfection		
Transfection	was	used	to	overexpress	proteins	and	visualize	their	localization	patterns.	
Cotransfections	of	2	plasmids	used	a	total	of	2µg	plasmid,	1µg	of	each	plasmid.	24	hours	
post	seeding,	plasmids	were	thawed	and	spun	using	the	bench	minicentriuge.	In	the	
hood,	the	2µg	of	plasmid	were	incubated	in	250	µL	Opti-MEM	(Invitrogen)	and	4	µL	
Lipofectamine	2000	(Invitrogen)	was	incubated	in	250	µL	Opti-MEM	(Invitrogen)	for	5	
minutes.		250	µL	of	the	Lipofectamine	2000	Opti-MEM	solution	was	added	to	each	2µg	
plasmid	and	Opti-MEM	solution	to	a	total	of	approximately	500	µL	solution.	This	
solution	incubated	for	20	minutes.	6	well	plates	were	labeled	with	the	appropriate	
transfection,	and	following	incubation	the	Lipofectamine--plasmid	complex	was	added	
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to	the	appropriately	well.	Cells	were	incubated	at	37°C	for	4-8	hrs.	Transfection	medium	
was	removed	and	fresh	medium	was	added.		
Immunostaining		
24	hours	post	transfection,	seeded	cover	slips	were	checked	for	confluencey	using	a	
light	microscope.	Cells	were	moved	to	the	bench	to	aspirate	off	the	medium	into	a	
bleach	containing	flask.	Following	the	aspiration,	each	well	was	washed	three	times	with	
1x	DPBS	for	15	seconds.	Cells	were	then	fixed	in	3mL	of	3.7%	formaldehyde	solution	
(ThermoFisher	Scientific)	for	10	minutes	in	the	fume	hood.	Cells	were	washed	three	
times	with	1x	DPBS	for	5	minutes	each	wash.	The	cells	were	made	porous	in	a	0.2%	
Triton	X	solution	(Acros	Organics).	Cells	were	again	washed	3	times	for	5	minutes	each	in	
2mL	1x	DPBS.	Using	tweezers,	cover	slips	were	flipped	on	30	µL	of	antibody	solution	on	
parafilm	in	a	humidity	chamber.	The	solution	contained	1.5%	goat	serum	(Santa-Cruz	
Biotech)	and	1:300	anti-FLAG	(Invitrogen)	antibody	diluted	in	1x	DPBS.	Coverslips	were	
allowed	to	incubate	in	primary	antibody	for	one	hour	at	room	temperature.	Following	
incubation,	the	coverslips	were	moved	back	into	their	specified	wells	and	washed	3	
times	for	5	minutes	with	1xDPBS.	The	coverslips	were	than	placed	on	the	primary	
antibody	solution	using	the	same	procedure	as	primary	except	a	1:400	ratio	of	cy3	anti-
mouse	(Sigma).	The	humidifying	chamber	was	placed	in	a	dark	drawer	for	the	40	minute	
incubation	period	as	the	secondary	antibody	is	light	sensitive.	Following	incubation,	the	
coverslips	were	moved	back	into	their	specified	wells	and	washed	with	1x	DPBS	for	5	
minutes	each.	During	the	wash	period,	the	6	well	plate	containing	the	coverslip	was	
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placed	in	a	dark	drawer.	Coverslips	were	mounted	on	glass	slides	using	the	Flouro-Gel	II	
with	DAPI	(Electron	Microscopy	Science).		
Fluorescence	Microscopy	
Slides	were	blinded	and	scored	using	a	Nikon	Eclipse	Ti	fluorescence	microscope.	The	
20x	objective	was	used	for	aggresome	presence	and	the	40x	objective	was	used	for	
colocalization.	100	cells	were	scored	for	presence	of	aggresomes.	Aggresomes	were	
classified	as	green	fluorescing	aggregates.	20	aggresome	presenting	cells	were	scored	
for	the	colocalization	of	MK-STYX	or	MK-STYXactive	or	pMT2.	Each	experiment	was	
repeated	3	times.		
Results		
	
MK-STYX	colocalizes	to	GFP-250	aggresomes		
Prior	studies	show	that	MK-STYX	does	not	colocalize	to	stress	granules	(Hinton	et	
al.,	2010).	Since	aggresome	formation	is	associated	with	stress	granule	formation,	we	
hypothesized	that	MK-STYX	would	colocalize	to	aggresomes.	The	aggresomal	marker	
protein	chimera	115	(GFP-250)	is	commonly	used	in	colocalization	studies,	and	was	one	
of	the	first	markers	used	to	characterize	aggresomes.	GFP	is	fused	at	the	COOH	terminus	
of	a	250	amino	acid	fragment	of	p115	(Garcia-Mata	et	al.,	1999).	p115	is	a	cytosolic	
membrane	transport	factor	that	localizes	to	the	Golgi	body	(Waters	et	al.,	1992;	
Nakamura	et	al.,	1997).	In	the	García-Mata	et	al.,	1999	study,	GFP-250	triggered	
aggresome	formation	in	approximately	50%	of	COS-7	cells.	In	this	study	GFP-250	
triggered	the	formation	of	aggresomes	in	approximately	90%	of	transfected	HeLa	cells	
(Figure	3).		
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	 Fluorescence	microscopy	and	immunostaining	were	used	to	determine	the	
amount	of	cells	presenting	aggresomes.	There	was	no	statistically	significant	difference	
in	HeLa	cells	presenting	aggresomes	in	GFP-250	and	MK-STYX	cotransfection	in	
comparison	to	GFP-250	and	MK-STYXactive	and	GFP-250	and	pMT2,	the	empty	plasmid	
vector	(Figure	3).	
	 In	75%	of	HeLa	cells	presenting	aggresomes,	MK-SYTX	colocalized	to	GFP-250	
aggresomes.	The	active	mutant	MK-STYXactive	colocalized	to	GFP-250	aggresomes	in	
81.5%	of	aggresome	presenting	cells.	The	pMT2	control	and	GFP-250	cotransfected	cells	
showed	no	colocalization,	ensuring	the	validity	of	the	colocalizations	(Figure	4).	These	
results	demonstrate	that	both	MK-STYX	and	MK-STYXactive	colocalize	to	GFP-250-induced	
aggresomes	and	MK-STYX	colocalizes	independent	of	its	non-catalytic	motif.	
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Figure	3	MK-STYX	impact	on	the	number	of	aggresome	presenting	cells.	Cells	were	scored	based	on	whether	or	not	
they	presented	aggresomes.	100	cells	were	scored	for	each	cotransfection.	Cells	cotransfected	with	GFP-250	and	MK-
STYX	have	slightly	fewer	aggresome	presenting	cells.	Triplicates	were	performed.	
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Figure	4	MK-STYX	colocalizes	to	GFP-250	aggresomes.	Cells	were	scored	for	localization	of	MK-STYX	or	
MK-STYXactive	to	aggresomes.	20	cells	were	counted	for	each	cotransfection.	MK-STYX	or	MK-STYXactive	
aggregates	colocalizing	with	GFP-250	aggresomes	were	scored.	75%	of	cells	cotransfected	with	MK-STYX	
and	GFP-250	showed	colocalization.	In	78%	of	cells	expressing	MK-STYXactive	and	GFP-250,	MK-STYXactive	
colocalized	with	aggresomes.	Triplicates	were	performed.	
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Figure	5.	HeLa	cells	were	cotransfected	with	FLAG-tagged	MK-STYX	or	MK-STYXactive	and	GFP-250	or	GFP.	Cells	were	stained	with	
anti-FLAG	(1:300	Invitrogen)	and	cy3	red	anti-mouse	(1:400	Sigma)	and	examined	by	fluorescence	microscopy.	GFP-250	presents	
with	larger	perinuclear	aggregates	and	nuclear	deformation.	MK-STYX	cotransfection	with	GFP-250	shows	its	localization	to	the	large	
GFP-250	aggresomes.	Active	mutant	MK-STYXactive		displays	similar	results	to	MK-STYX.	MK-STYXactive	colocalizes	to	large	GFP-250	
aggresomes.	Empty	vector	pMT2	expressed	with	GFP-250	aggresomes	did	not	fluoresce	showing	MK-STYX	and	MK-STYXactive	
fluorescence	was	not	due	to	bleed-through.	MK-STYX	was	cotransfected	with	GFP.	MK-STYXactive	was	cotransfected	with	GFP.	Control	
pMT2	was	cotransfection	with	GFP.		
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MK-STYX	colocalizes	to	v-ErbA	aggresomes	
	
The	protein	content	of	aggresomes	depends	on	the	stressor	that	induces	
aggresome	formation	(Tyedmers	et	al.,	2010).	To	ensure	that	MK-STYX	localizes	to	more	
than	one	type	of	aggresome,	we	cotransfected	using	a	different	aggresomal	marker.	
Gag-v-ErbA	(p75gag-v-erb-A)	is	an	aggresome	marker	whose	over	expression	is	sufficient	to	
induce	aggresome	formation	(Bondzi	et	al.,	2011).	v-ErbA	is	an	oncoprotein	and	a	highly	
mutated		retroviral	variant	of	thyroid	hormone	receptor	α	1	(TRα1).	v-ErbA	dimerizes	
with	the	nuclear	receptors	retinoid	X	receptor	and	TRα1,	resulting	in	the	sequestration	
of	these	receptors	to	perinuclear	aggresomes	(Bonamy	et	al.,	2005;	Bondzi	et	al.,	2011).	
v-ErbA	aggresomes	are	morphologically	different	from	GFP-250	aggresomes.	v-ErbA	
aggresomes	are	ribbon	like	while	GFP-250	aggresomes	are	spherical	(Bondzi	et	al.,	2011;	
Garcia-Mata	et	al.,	1999).	The	comparison	of	two	aggresome	morphologies	provides	
further	insight	into	the	variety	of	MK-STYX	colocalized	aggresomes.		
Previous	studies	showed	49%	of	v-ErbA	transfected	HeLa	cells	demonstrated	
aggresome	formation	(Bondzi	et	al.,	2011).	We	show	that	40%	of	v-ErbA	and	pMT2	
empty	vector	cotransfected	HeLa	cells	presented	aggresomes,	33%	of	v-ErbA	and	MK-
STYX	cotransfected	cells	demonstrated	aggresome	formation,	and	43%	of	MK-STYXactive	
and	v-ErbA	cotransfected	cells	demonstrated	aggresomes	formation	(Figure	6).	Given	
the	intercellular	variables,	these	differences	were	not	statistically	significant.	
In	68%	of	v-ErbA	induced	aggresome	presenting	cells,	MK-STYX	colocalized	to	v-
ErbA	aggresomes.	In	76%	of	aggresome	presenting	cells,	MK-STYXactive	colocalized	to	v-
ErbA	aggresomes	(one-way	ANOVA;	F-value=141.03.55,	p-value=0.009x10-3).	We	saw	no	
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colocalization	in	aggresome	presenting	cells	with	the	pMT2	control	(Figure	7).	These	
results	demonstrate	MK-STYX	and	MK-STYXactive	colocalization	to	aggresomes.	
Furthermore,	they	demonstrate	that	MK-STYX	colocalization	to	aggresomes	is	
independent	of	its	pseudophosphatase	catalytic	inability.			
	
	
	
	
Figure	6	MK-STYX	impact	on	v-ErbA	aggresome	presenting	cells.	Cells	were	scored	
based	on	whether	or	not	they	presented	aggresomes.	100	cells	were	scored	for	each	
cotransfection.	Cells	cotransfected	with	v-ErbA	and	MK-STYX	appear	to	have	slightly	
fewer	aggresome	presenting	cells.	Triplicates	were	performed.		
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Figure	7	MK-STYX	colocalizes	to	v-ErbA	aggresomes.	The	percentages	of	aggresome	
cotransfected	cells	with	MK-STYX	or	MK-STYXactive	co	localizing	with	v-ErbA	were	scored.	
In	68%	of	cells	expressing	MK-STYX	and	v-ErbA,	MK-STYX	colocalized	to	aggresomes	and	
in	76%	of	cells	expressing	MK-STYXactive	and	v-ErbA,	MK-STYXactive	colocalized	to	
aggresomes.	Triplicates	were	preformed.				
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Figure	8	MK-STYX	colocalizes	to	v-ErbA	aggresomes.	HeLa	cells	were	cotransfected	with	FLAG-tagged	MK-STYX,	MK-
STYXactive	or	control	pMT2	and	with	v-ErbA	or	GFP.	Cells	were	stained	with	anti-FLAG	(1:300	Invitrogen)	and	cy3	anti-
mouse	(1:400	Sigma)	and	examined	by	fluorescence	microscopy.	v-ErbA	aggresomes	display	their	characteristic	
ribbon	like	structure	and	smaller	aggregates.	Cells	expressing	v-ErbA	aggresomes	displayed	MK-STYX	localizing	to	the	
large	aggresome	and	smaller	aggregates.	Active	mutant	MK-STYXactive	displays	similar	results	to	MK-STYX.	MK-
STYXactive	localizes	v-ErbA	aggresomes.	Empty	vector	pMT2	expressed	v-ErbA	aggresomes	did	not	fluoresce	showing	
MK-STYX	and	MK-STYXactive	fluorescence	was	not	due	to	bleed-through.	MK-STYX	was	cotransfected	with	GFP.	MK-
STYXactive	was	cotransfected	with	GFP.	Control	pMT2	cotransfection	with	GFP.		
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MK-STYX	does	not	colocalize	to	G3BP1	stress	granules		
Previous	studies	in	this	lab	demonstrated	that	MK-STYX	inhibits	the	formation	of	
stress	granules,	but	does	not	localize	to	stress	granules	(Barr	et	al.,	2013;	Hinton	et	al.,	
2010).	To	demonstrate	that	MK-STYX	colocalizes	specifically	to	aggresomes	and	not	all	
aggregates,	this	study	was	replicated	using	the	same	methodology	as	the	GFP-250	and	
v-ErbA	aggresome	studies.	Overexpression	of	G3BP1	resulted	in	stress	granules.	
Supporting	Barr	et	al.,	2013	there	were	significantly	fewer	cells	presenting	stress	
granules	in	cells	cotransfected	with	GFP	tagged	G3BP1	and	MK-STYX	in	comparison	to	
cells	cotransfected	with	G3BP1	and	either	MK-STYXactive	or	the	pMT2	vector.	In	cells	
cotransfected	with	MK-STYX,	stress	granules	were	difficult	to	find.	In	the	few	stress	
granule	containing	cells	observed,	stress	granules	appeared	much	smaller.		MK-STYX	did	
not	colocalize	to	these	aggregates	(Figure	9).			
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Figure	9	MK-STYX	does	not	colocalize	to	stress	granules.	HeLa	cotransfection	of	stress	
granule	marker	FITC	tagged	G3BP1	and	FLAG	tagged	MK-STYX,	MK-STYXactive	or	pMT2	
vector	were	fixed	and	stained	with	anti-FLAG	and	cy3-conjugated	goat	anti-mouse.	
Cotransfection	of	G3BP1	and	FLAG-tagged	MK-STYX	shows	MK-STYX	is	cytosolic	while	
G3BP1	forms	stress	granules.	MK-STYX	does	not	localize	to	stress	granules.	Active	
mutant	MK-STYXactive	is	co	transfected	with	G3BP-1	and	appears	cytosolic,	showing	MK-
STYXactive	does	not	localize	to	stress	granules.	
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Discussion		
	
	 Taken	together	these	results	demonstrate	that	MK-STYX	colocalizes	to	specific	
aggregating	bodies	called	aggresomes.	MK-STYX	colocalizes	to	GFP-250	spherical	
aggresomes	and	v-ErbA	ribbon	like	aggresomes.	MK-STYX	does	not	colocalize	to	any	
aggregating	body	as	it	does	not	colocalize	to	G3BP1	induced	stress	granules,	which	are	
aggregates	of	mRNA	and	proteins.		
Prior	studies	show	that	over-expression	of	G3BP1	induces	the	formation	of	stress	
granules	dependent	on	its	phosphorylation	state.	In	addition,	MK-STYX	binds	with	
G3BP1	and	inhibits	stress	granule	formation	independent	of	its	phosphorylation	state,	
signifying	MK-STYX	is	inhibiting	stress	granule	formation	upstream	of	G3BP1	(Barr	et	al.,	
2013).	Results	presented	here	confirm	that	MK-STYX	inhibits	stress	granule	formation,	
but	also	show	the	novel	finding	that	MK-STYX	colocalizes	to	aggresomes.	This	
demonstrates	the	possibility	of	a	larger	regulatory	role	of	MK-STYX	in	the	stress	
response	pathway.		
	 We	hypothesized	MK-STYX	would	inhibit	aggresome	formation	similar	to	its	
inhibition	of	stress	granule	formation.		We	observed	some	decreased	in	aggresome	
formation	in	the	presence	of	MK-STYX.	Aggresomes	were	allowed	to	form	for	24	hours	
post	transfection	before	immunostaining	and	scoring;	however,	v-ErbA	aggresomes	do	
not	fully	form	until	48hrs	post	transfection	(Bondzi	et	al.,	2011).	There	still	remains	the	
possibility	that	MK-STYX	inhibits	aggresome	formation,	and	that	significant	differences	
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could	be	seen	following	a	longer	incubation	time	and	or	with	proteasome	inhibition	to	
increase	aggresome	size.		
We	are	at	the	initial	stages	of	characterizing	MK-STYX’s	role	in	the	aggresome	life	
cycle.	MK-STYX	colocalizes	to	two	distinct	aggresome	morphologies	and	follow-up	
studies	may	indicate	a	role	in	aggresome	inhibition.	Future	steps	include	further	
characterizing	MK-STYX	role	in	aggresome	formation	as	well	as	potential	interacting	
partners	within	aggresomes.			
MK-STYX	interacts	with	G3BP1,	a	protein	that	nucleates	stress	granules	and	
binds	a	characteristic	aggregate	forming	protein	in	many	neurodegenerative	diseases,	
the	protein	tau.	Tau	has	been	suggested	to	modulate	stress	granules	as	well	as	neurite	
outgrowth	(Vanderweyde	et	al.,	2012).	Interestingly,	this	lab	reported	that	MK-STYX	
induces	neurite	outgrowth	in	rat	PC12	cells	and	neurons	(Flowers	et	al.,	2014).	We	have	
also	shown	that	MK-STYX	changes	tau	localization	in	PC12	cells	(unpublished).	
Furthermore,	the	tau	isoforms	1N4R	and	2N4R	form	aggresomes	(Guthrie	&	Kraemer,	
2011;	Santa-Maria	et	al.,	2012).	MK-STYX	colocalizes	to	two	aggresome	morphologies	
and	may	be	colocalizing	to	tau	aggresomes,	regulating	tau	involvement	in	the	stress	
response	pathway.		
	 Tau	aggregates,	stress	granules	and	aggresomes	are	characteristics	of	many	life	
threatening	neurodegenerative	diseases.	Overactive	stress	granule	formation	stimulates	
pathological	changes	associated	with	tau	and	accelerates	the	pathophysiology	of	
protein	aggregation	in	ND	(Vanderweyde	et	al.,	2013).	It	has	been	suggested	that	the	
aggregation	of	pathological	proteins	such	as	tau	stimulate	the	formation	of	overactive	
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stress	granules	in	a	positive	feedback	loop.	SG	formation	is	associated	with	aggresome	
formation	(Wolozin,	2012).	Tau	aggresomes	form	in	the	presence	of	paired	helical	
filaments	and	are	suggested	to	be	the	first	step	in	neurofibrillary	tangle	(NFT)	
development,	a	hallmark	of	AD.		
The	pseudophosphatase	MK-STYX	inhibits	stress	granule	formation	and	localizes	
to	aggresomes,	with	implications	of	a	larger	regulatory	role	in	the	stress	response	
pathway.	This	thesis	research	provides	a	crucial	and	fundamental	step	in	understanding	
the	role	of	MK-STYX	in	the	stress	response	pathway	by	characterizing	its	localization.	
Future	steps	include	the	characterization	of	MK-STYX	and	tau	aggresomes	formation	
and	dynamics.	This	characterization	along	with	MK-STYX	established	localization	to	
aggresomes	could	provide	essential	insight	into	neurodegenerative	disease	
development	and	future	therapies.			
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